[ad_1]
By Jody Godoy
SAN JOSE, Calif. (Reuters) -The founder of Theranos Elizabeth Holmes has denied any wrongdoing in connection with the start of a blood test during cross-examination on Tuesday, when her defense against fraudulent charges was nearing completion.
Former Theranos dealers have testified in the case that Holmes led them to believe that the company’s expertise was being used by US troops in the process. Asked by state attorney Robert Leach, Holmes said he had never said this to investors and it would not have been true.
Holmes became famous in Silicon Valley for his keen interest in re-examining the disease. But he has been on trial for three months in a San Jose, California court, accused of exaggerating Theranos’ expertise to patients and bankers.
At a cost of $ 9 billion, Theranos collapsed after the Wall Street Journal published a number of articles, starting in 2015, which showed his weapons were flawed and faulty.
In his defense, Holmes testified that he believed that Theranos could achieve its goal of having a small device that would make blood tests cheaper and more readily available.
Holmes described some of his actions, such as trying to block the Wall Street Journal article on Theranos, saying his goal was to protect corporate secrets.
Leach has reportedly asked Holmes about the allegations, which he also used to justify Theranos’ use of the Walgreens blood test machine.
The pharmacy had a partnership with Theranos to offer blood tests in some of its stores.
Holmes’ lawyer says his defense case is expected to end this week.
Fusion Media or anyone involved with Fusion Media would not accept any liability for any loss or damage as a result of reliance on information including data, documents, charts and buy / sell tokens contained within this website. Please know more about the risks and costs associated with trading the financial markets, this is one of the most risky ways to earn money.
[ad_2]
Source link
